Is a complete PASG research report available?

No complete published report is available for Passage Bio, Inc. (PASG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Passage Bio, Inc. (PASG)

NASDAQ: PASG · USD

$3.40

+0.05 (+1.5%)· Recorded snapshot

Market cap	10.9M
Net income (ttm)	-36.1M
EPS (ttm)	-$11.3
Shares out	3.2M
Volume	7,731
Beta	1.39

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -36.1M
EPS (ttm): -$11.3
Market cap: 10.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0001787297
Company name	Passage Bio, Inc.
Country	United States
Country code	US
CUSIP number	702712209
Earnings date	2026-11-09
Earnings time	bmo
Employees	24
Employees change	-36
Employees growth	-60%
Enterprise value	$-13.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
Industry	Biotechnology
IPO date	2020-02-28
Is primary listing	Yes
Is SPAC	No
ISIN number	US7027122099
Last 10-K release date	2026-03-03
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split date	2025-07-14
Last stock split type	Reverse
Market cap	$10.9M
Market cap category	Nano-Cap
Next earnings date	2026-11-09
Options	No
Price	$3.40
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	PASG
U.S. state	Pennsylvania
Website	https://www.passagebio.com

Metric

Value

Amount currency

USD

CIK code

0001787297

Company name

Passage Bio, Inc.

Country

United States

Country code

CUSIP number

702712209

Earnings date

2026-11-09

Earnings time

bmo

Employees

Employees change

-36

Employees growth

-60%

Enterprise value

$-13.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2017

Industry

Biotechnology

IPO date

2020-02-28

Is primary listing

Yes

Is SPAC

ISIN number

US7027122099

Last 10-K release date

2026-03-03

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split date

2025-07-14

Last stock split type

Reverse

Market cap

$10.9M

Market cap category

Nano-Cap

Next earnings date

2026-11-09

Options

Price

$3.40

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

PASG

U.S. state

Pennsylvania

Website

https://www.passagebio.com

Metric	Value
Earnings yield	-332.61%
FCF / EV yield	250.46%
FCF yield	-310.77%
P/B ratio	2.42x
Price / tangible book value	2.42x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-332.61%

FCF / EV yield

250.46%

FCF yield

-310.77%

P/B ratio

2.42x

Price / tangible book value

2.42x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-1.5M
ROA	-45.62%
ROA (5Y)	-31.43%
ROCE	-854.82%
ROE	-169.09%
ROE (5Y)	-73.19%
ROIC	-70.6%

Metric

Value

Profit per employee

$-1.5M

ROA

-45.62%

ROA (5Y)

-31.43%

ROCE

-854.82%

ROE

-169.09%

ROE (5Y)

-73.19%

ROIC

-70.6%

Metric	Value
EPS growth quarters	2
EPS growth years	4
Net income growth quarters	2
Net income growth years	4
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Depreciation and amortization	$512,000
EBIT	$-38.1M
EBITDA	$-37.6M
EPS	$-11.31
FCF per share	$-10.41
Financing cash flow	$9,000
Free cash flow	$-33.5M
Free cash flow minus SBC	$-35.8M
Investing cash flow	$20,000
Net cash flow	$-33.5M
Net income	$-36.1M
Operating cash flow minus SBC	$-35.8M
Operating income	$-38.1M
Stock-based compensation	$2.3M

Metric

Value

Depreciation and amortization

$512,000

EBIT

$-38.1M

EBITDA

$-37.6M

EPS

$-11.31

FCF per share

$-10.41

Financing cash flow

$9,000

Free cash flow

$-33.5M

Free cash flow minus SBC

$-35.8M

Investing cash flow

$20,000

Net cash flow

$-33.5M

Net income

$-36.1M

Operating cash flow minus SBC

$-35.8M

Operating income

$-38.1M

Stock-based compensation

$2.3M

Metric	Value
Book value per share	$1.38
Debt / equity	0
Long-term assets	$0
Long-term liabilities	$0
Net cash (debt)	$24.2M
Net cash / market cap	224.08%
Net cash growth	-26.57%
Net debt / equity	-5.42
Piotroski F-Score	1
Shareholders' equity	$4.5M
Tangible book value	$4.5M
Tangible book value per share	$1.38
Total assets	$25.2M
Total cash	$24.2M
Total debt	$0
Total liabilities	$20.7M
WACC	11.92%

Metric

Value

Book value per share

$1.38

Debt / equity

Long-term assets

Long-term liabilities

Net cash (debt)

$24.2M

Net cash / market cap

224.08%

Net cash growth

-26.57%

Net debt / equity

-5.42

Piotroski F-Score

Shareholders' equity

$4.5M

Tangible book value

$4.5M

Tangible book value per share

$1.38

Total assets

$25.2M

Total cash

$24.2M

Total debt

Total liabilities

$20.7M

WACC

11.92%

Metric	Value
Current assets	$25.2M
Current liabilities	$20.7M
Current ratio	1.22
Net working capital	$-19.7M
Quick ratio	1.17
Working capital	$4.5M

Metric

Value

Current assets

$25.2M

Current liabilities

$20.7M

Current ratio

1.22

Net working capital

$-19.7M

Quick ratio

1.17

Working capital

$4.5M

Metric	Value
Buyback yield / dilution	-1.12%
Dividend yield	0%
Shareholder yield	-1.12%

Metric

Value

Buyback yield / dilution

-1.12%

Dividend yield

Shareholder yield

-1.12%

Metric	Value
150-day SMA	$5.26
1D price change	1.49%
1M price change	-30.63%
1M total return	-30.63%
1W price change	-7.5%
1W total return	-7.5%
1Y price change	-53.75%
1Y return CAGR	-53.77%
1Y total return	-53.75%
20-day SMA	$3.72
200-day SMA	$6.36
3M price change	-27.92%
3M total return	-27.92%
3Y price change	-73.78%
3Y return CAGR	-35.99%
3Y total return	-73.78%
50-day SMA	$4.31
50-day SMA vs 200-day SMA	50under200
52-week high	$20.00
52-week high date	2026-01-09
52-week low	$3.29
52-week low date	2026-06-25
5Y price change	-98.04%
5Y return CAGR	-54.44%
5Y total return	-98.04%
6M price change	-41.68%
6M total return	-41.68%
All-time high	$764.60
All-time high date	2020-06-24
All-time low	$3.29
All-time low date	2026-06-25
Average true range (ATR)	$0.29
Average volume	17K
Beta (1Y)	3.73
Beta (2Y)	2.24
Beta (5Y)	1.39
Change from 52-week high	-83%
Change from 52-week low	3.34%
Change from all-time high	-99.56%
Change from all-time low	1.22%
Change from open	0%
Day's gap	1.49%
Dollar volume	$26,285
High price	$3.40
Low price	$3.40
Monthly RSI	34.67
Open price	$3.40
Premarket change	0%
Premarket close	$3.35
Premarket price	$3.35
Previous close	$3.35
Price vs 150-day SMA	-36.67%
Price vs 20-day SMA	-10.56%
Price vs 200-day SMA	-47.66%
Price vs 50-day SMA	-22.81%
Relative volume	0.46
Return from IPO open	-99.25%
Return from IPO price	-81.39%
RSI	33.12
Sharpe ratio	-0.11
Sharpe ratio (3Y)	0.13
Sharpe ratio (5Y)	-0.34
Sortino ratio	-0.11
Sortino ratio (3Y)	0.27
Sortino ratio (5Y)	-0.47
Volume	7.7K
Weekly RSI	36.47
YTD price change	-71.78%
YTD total return	-71.78%

Metric

Value

150-day SMA

$5.26

1D price change

1.49%

1M price change

-30.63%

1M total return

-30.63%

1W price change

-7.5%

1W total return

-7.5%

1Y price change

-53.75%

1Y return CAGR

-53.77%

1Y total return

-53.75%

20-day SMA

$3.72

200-day SMA

$6.36

3M price change

-27.92%

3M total return

-27.92%

3Y price change

-73.78%

3Y return CAGR

-35.99%

3Y total return

-73.78%

50-day SMA

$4.31

50-day SMA vs 200-day SMA

50under200

52-week high

$20.00

52-week high date

2026-01-09

52-week low

$3.29

52-week low date

2026-06-25

5Y price change

-98.04%

5Y return CAGR

-54.44%

5Y total return

-98.04%

6M price change

-41.68%

6M total return

-41.68%

All-time high

$764.60

All-time high date

2020-06-24

All-time low

$3.29

All-time low date

2026-06-25

Average true range (ATR)

$0.29

Average volume

17K

Beta (1Y)

3.73

Beta (2Y)

2.24

Beta (5Y)

1.39

Change from 52-week high

-83%

Change from 52-week low

3.34%

Change from all-time high

-99.56%

Change from all-time low

1.22%

Change from open

Day's gap

1.49%

Dollar volume

$26,285

High price

$3.40

Low price

$3.40

Monthly RSI

34.67

Open price

$3.40

Premarket change

Premarket close

$3.35

Premarket price

$3.35

Previous close

$3.35

Price vs 150-day SMA

-36.67%

Price vs 20-day SMA

-10.56%

Price vs 200-day SMA

-47.66%

Price vs 50-day SMA

-22.81%

Relative volume

0.46

Return from IPO open

-99.25%

Return from IPO price

-81.39%

RSI

33.12

Sharpe ratio

-0.11

Sharpe ratio (3Y)

0.13

Sharpe ratio (5Y)

-0.34

Sortino ratio

-0.11

Sortino ratio (3Y)

0.27

Sortino ratio (5Y)

-0.47

Volume

7.7K

Weekly RSI

36.47

YTD price change

-71.78%

YTD total return

-71.78%

Metric	Value
Float	3.2M
Float percentage	99.59%
Shares change (QoQ)	0.09%
Shares change (YoY)	1.12%
Shares held by insiders	0.41%
Shares held by institutions	50.76%
Shares outstanding	3.2M
Short % of float	2.15%
Short % of shares	2.14%
Short ratio	3.4 days

Metric

Value

Float

3.2M

Float percentage

99.59%

Shares change (QoQ)

0.09%

Shares change (YoY)

1.12%

Shares held by insiders

0.41%

Shares held by institutions

50.76%

Shares outstanding

3.2M

Short % of float

2.15%

Short % of shares

2.14%

Short ratio

3.4 days

Passage Bio, Inc. (PASG)

Price

Financial snapshot

Fair-value bridge

Latest news · PASG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PASG indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PASG

Frequently asked questions